What is he best known for?
The fields of study he is best known for:
- Gene
- Cancer
- Internal medicine
Guillermo Velasco spends much of his time researching Cannabinoid, Cell biology, Protein kinase B, Autophagy and Pharmacology.
His Cannabinoid research integrates issues from Cancer research, Glioma, Downregulation and upregulation and Cannabinoid receptor, Cannabinoid receptor type 2.
His Cell biology research is multidisciplinary, incorporating elements of Cancer cell and Apoptosis, Ceramide.
His work is dedicated to discovering how Autophagy, Programmed cell death are connected with Autophagosome, Sequestosome 1, Computational biology, Physiology and Cannabinoid Receptor Agonists and other disciplines.
Guillermo Velasco combines subjects such as Tetrahydrocannabinol and Bioinformatics with his study of Pharmacology.
The various areas that he examines in his Bioinformatics study include Autophagy-Related Protein 7, Autophagosome maturation, Autophagosome membrane, Autophagy database and Neuroscience.
His most cited work include:
- Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (4170 citations)
- Guidelines for the use and interpretation of assays for monitoring autophagy (3242 citations)
- Autophagy in malignant transformation and cancer progression (686 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Internal medicine, Oncology, Cancer research, Cell biology and Renal cell carcinoma.
In Internal medicine, Guillermo Velasco works on issues like Endocrinology, which are connected to Cannabinoid receptor.
His research investigates the connection with Oncology and areas like Cancer which intersect with concerns in Bioinformatics.
His study in Cell biology is interdisciplinary in nature, drawing from both Autophagy, Apoptosis and Ceramide.
Guillermo Velasco has included themes like Cancer cell, Unfolded protein response, Programmed cell death and Cell growth in his Autophagy study.
In his study, which falls under the umbrella issue of Cannabinoid, Pharmacology is strongly linked to Protein kinase B.
He most often published in these fields:
- Internal medicine (34.78%)
- Oncology (26.96%)
- Cancer research (23.91%)
What were the highlights of his more recent work (between 2018-2021)?
- Internal medicine (34.78%)
- Oncology (26.96%)
- Renal cell carcinoma (19.13%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Internal medicine, Oncology, Renal cell carcinoma, Cancer research and Cancer.
The concepts of his Oncology study are interwoven with issues in Nivolumab, Ipilimumab, Targeted therapy and Prostate cancer.
His Cancer research research includes elements of Autophagy, Cell, Cisplatin, Immune checkpoint inhibitors and PI3K/AKT/mTOR pathway.
His biological study spans a wide range of topics, including Cancer cell, Human disease, Kinase, Cell biology and Programmed cell death.
His Programmed cell death research entails a greater understanding of Apoptosis.
His work in the fields of Prostate and Carcinogenesis overlaps with other areas such as Pandemic and Loss of heterozygosity.
Between 2018 and 2021, his most popular works were:
- Inhibition of a G9a/DNMT network triggers immune-mediated bladder cancer regression. (42 citations)
- Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) (38 citations)
- Sequencing and Combination of Systemic Therapy in Metastatic Renal Cell Carcinoma (26 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Cancer
- Internal medicine
Guillermo Velasco mostly deals with Internal medicine, Oncology, Cancer research, Renal cell carcinoma and Autophagy.
He interconnects Molecular heterogeneity, Precision medicine, Carcinoma and Ipilimumab in the investigation of issues within Oncology.
The Cancer research study combines topics in areas such as Bladder cancer, Cisplatin, Hypoxia-inducible factors, Predictive marker and PTEN.
His study in the field of Sunitinib also crosses realms of Context.
His Autophagy research incorporates themes from Cell, Cancer cell, Cancer, Cell biology and Programmed cell death.
His research integrates issues of Immune checkpoint, Chaperone-mediated autophagy, Protein sumoylation and Computational biology in his study of Programmed cell death.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
